chrX-9688115-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005647.4(TBL1X):āc.456G>Cā(p.Glu152Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,096,226 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005647.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBL1X | NM_005647.4 | c.456G>C | p.Glu152Asp | missense_variant | 7/18 | ENST00000645353.2 | |
TBL1X | NM_001139466.1 | c.456G>C | p.Glu152Asp | missense_variant | 7/18 | ||
TBL1X | NM_001139467.1 | c.303G>C | p.Glu101Asp | missense_variant | 6/17 | ||
TBL1X | NM_001139468.1 | c.303G>C | p.Glu101Asp | missense_variant | 7/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBL1X | ENST00000645353.2 | c.456G>C | p.Glu152Asp | missense_variant | 7/18 | NM_005647.4 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1096226Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 361864
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2023 | The c.456G>C (p.E152D) alteration is located in exon 7 (coding exon 4) of the TBL1X gene. This alteration results from a G to C substitution at nucleotide position 456, causing the glutamic acid (E) at amino acid position 152 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at